The phaware® interview

SPECIAL EDITION PHAWARE® PODCAST: Beyond the Basics

The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers.

Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. …


The phaware® interview

Sheila Gujrathi, MD and Larry Zisman, MD of Gossamer Bio discuss the development of an investigational new treatment for pulmonary arterial hypertension and their Phase 2 Clinical Trial for GB0002.

Learn more about their Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension (PAH): https://clinicaltrials.gov/ct2/show/NCT03926793

Sheila Gujrathi, MD:
My name is Dr. Sheila Gujrathi. I’m the Co-Founder, CEO, and Chief Medical Officer of Gossamer Bio, which is a clinical-stage biopharmaceutical company located in San Diego, California. …


The phaware® interview

Dr. Raymond Benza is the Director for the Division of Cardiovascular Medicine at “THE” Ohio State University. He has been in practice for more than 20 years. In this episode, Dr. Benza discusses GossamerBio’s GB002 Phase 2 Study and explains what differentiates GB002 from other investigational drugs in development.

Raymond Benza, MD:
Well, good day, everyone. I hope everyone is staying safe in these crazy days. My name is Dr. Raymond Benza and I am currently the Director for the Division of Cardiovascular Medicine at “THE” Ohio State University. I am also a PH Clinician and Researcher…


The phaware® interview

SPECIAL EDITION PHAWARE® PODCAST: Moving Forward

The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers.

Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH.


The phaware® interview

David F. Harris founded Insight & Measurement and provides research, training and speaking to the industry.

In this episode, he discusses the qualitative and quantitative work that he conducts with PAH patients, so that people who get invited to be part of these types of studies have some understanding of what actually the process is like and what gets done with those results.

My name is David Harris. I run a company called Insight & Measurement, and we do a lot of work in rare diseases and in healthcare. My background has always been in healthcare…


The phaware® interview

SPECIAL EDITION PHAWARE® PODCAST: The Pathways To Treatment

The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers.

Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. …


The phaware® interview

SPECIAL EDITION PHAWARE® PODCAST: How Decisions Today Can Shape the Future

The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers.

Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. …


The phaware® interview

SPECIAL EDITION PHAWARE PODCAST:
Roham Zamanian, MD from Stanford University Medical Center discusses Coronavirus (COVID-19) and gives Specific Advice for the Pulmonary Hypertension Community.

Stay up to date with the latest on Coronavirus Disease 2019 at the CDC website.

Roham Zamanian, MD

My name is Roham Zamanian. I’m the Medical Director of the Adult Pulmonary Hypertension Program at Stanford University Medical Center and I’m here talk to you a little bit about what’s going on with coronavirus and the specifics of what our pulmonary hypertension community and pulmonary hypertension patients should be thinking about.

I think the first place…


The phaware® interview

SPECIAL EDITION PHAWARE PODCAST: Victor F. Tapson, MD from Cedars-Sinai discusses coronavirus (COVID-19) and how it might impact Pulmonary Hypertension Patients.

Stay up to date with the latest on Coronavirus Disease 2019 at the CDC website.

Hi, I’m Vic Tapson. I’m in pulmonary critical care at Cedar Sinai Medical Center. Wanted to talk for a few minutes today about this coronavirus and how it might relate to PAH and how we should be reacting and some thoughts about this.

I think maybe the most important point to make first is while we’re taking this seriously, we…


The phaware® interview

Harold I. Palevsky, MD is a Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and the Chief of Pulmonary, Allergy and Critical Care Medicine at the Penn Presbyterian Medical Center in Philadelphia. He also heads the Pulmonary Vascular Disease Program at that campus. For the past 25 years, he has been recognized as one of Philadelphia Magazine’s and America’s Top doctors. In this episode, Dr.

phaware global association®

Are You #phaware? Pulmonary hypertension (PH) is a rare, life-threatening disease affecting the arteries of the lungs. www.phaware.global

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store